MedPath

Which is the better treatment for lung metastases from giant cell tumor of bone, metastasectomy or non-metastasectomy? A systematic review

Not Applicable
Conditions
ung metastases from giant cell tumor of bone
Registration Number
JPRN-UMIN000038826
Lead Sponsor
ara Medical University
Brief Summary

The mortality of the patients was similar in the metastasectomy and the nonmetastasectomy groups; the proportion of patients in the metastasectomy group who died of disease was 7.1% (6 of 85) compared with 17.0% (9 of 53) in the non-metastasectomy group; the overall pooled OR was 0.64 (95% CI, 0.24-1.68; P=.360), and the heterogeneity I2 was 0% (Figure A, available in the online version of the article).

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
138
Inclusion Criteria

Not provided

Exclusion Criteria

The patients who had inoperable lung metastases and were treated with observation, chemotherapy, or radiotherapy, were excluded.We excluded studies without a comparison group, those without a report of tumor-related death, isolated case reports or case series including fewer than five patients and non-English and non-Japanese language abstracts. We did not place any restrictions on the date of publication.

Study & Design

Study Type
Others,meta-analysis etc
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath